Ligand validation:4LR8

HSX: 5-O-phosphono-alpha-D-ribofuranose

HSX is a Ligand Of Interest in 4LR8 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4LR8_HSX_A_406	44%	53%	0.138	0.863	0.66	1.15	-	2	0	0	100%	0.75
4LR8_HSX_A_407	27%	61%	0.229	0.879	0.54	0.96	-	1	3	0	100%	0.5
4LRF_HSX_A_406	83%	56%	0.098	0.956	0.61	1.06	-	1	0	0	100%	0.75
3M8Z_HSX_A_401	69%	51%	0.118	0.932	0.87	1.03	-	1	0	0	100%	0.75
5VN4_HSX_A_302	99%	62%	0.06	0.987	0.71	0.76	-	-	0	0	100%	1
1ZN7_HSX_A_506	98%	54%	0.065	0.987	0.79	0.97	-	-	1	0	100%	0.5
9MF6_HSX_C_501	97%	74%	0.054	0.968	0.48	0.54	-	-	0	0	100%	1
9DT7_HSX_B_302	96%	67%	0.063	0.971	0.48	0.79	-	1	0	0	100%	0.65
4L51_HSX_B_401	95%	0%	0.071	0.973	6.07	3.26	10	8	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.